Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622797 | SCV000742305 | likely pathogenic | Inborn genetic diseases | 2017-04-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001384919 | SCV001584609 | pathogenic | not provided | 2022-01-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly77 amino acid residue in GNB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27759915). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 224713). This missense change has been observed in individual(s) with GNB1-related neurodevelopmental delay and hypotonia (PMID: 27108799; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 77 of the GNB1 protein (p.Gly77Ser). |
Ce |
RCV001384919 | SCV001747424 | pathogenic | not provided | 2021-05-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001384919 | SCV001769566 | pathogenic | not provided | 2022-01-07 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27108799, 27759915, 29174093, 30504930) |
MGZ Medical Genetics Center | RCV002288841 | SCV002580998 | likely pathogenic | Intellectual disability, autosomal dominant 42 | 2022-07-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics Munich, |
RCV002288841 | SCV004045955 | pathogenic | Intellectual disability, autosomal dominant 42 | 2023-05-23 | criteria provided, single submitter | clinical testing | |
Genomics And Bioinformatics Analysis Resource, |
RCV001842964 | SCV000266334 | pathogenic | Global developmental delay; Hypotonia | 2016-02-10 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV000755059 | SCV000882875 | likely pathogenic | Seizure; Hypotonia; Neurodevelopmental Disability | 2016-05-05 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291375 | SCV001479849 | likely pathogenic | Autism spectrum disorder | no assertion criteria provided | research |